Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05112900 · ClinicalTrials.gov registry record · Phase 3
Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts)
A Phase 3 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 3
- Development phase
- 7,122
- Enrollment target
NCT05112900: Completed Phase 3 study, sponsored by University of Utah.
NCT05112900 is a Phase 3 study that has completed, run by University of Utah. The registered enrollment target is 7,122 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (823% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05112900, a Phase 3 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 7,122 participants
- Enrollment target
Study Summary
This project will address key testing challenges in Utah schools by building on collaborations with public school districts, private schools, charter schools and with Utah Department of Health on coronavirus disease (COVID-19) testing and existing infrastructure. The study team will work closely with schools and the Utah public health system to implement and test a shovel-ready and scalable health information technology approach that delivers automated text messages (TM) to students' parents around COVID-19 testing. In addition, some parents will receive a health navigator (HN) follow-up to ensure that tests are completed. Families will be offered the recently FDA-approved in-home serial testing approach if accessing in-person testing is a challenge. While this project is focused on COVID-19 testing, in the case that the COVID-19 vaccination becomes more relevant or is the priority of the school, the study team is able to tailor the intervention to focus on the vaccine as well. The outcomes in this study utilized parent/student reported data. Staff data were also collected but will not be reflected in primary outcome analyses.
Primary Outcome
The study team will examine whether students and/or members of their household tested by analyzing the number of valid responses that confirmed COVID-19 testing was completed by households
Interventions
- BEHAVIORAL Text Messaging (TM)
- BEHAVIORAL Text Messaging + Health Navigation (TM+HN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,122 participants |
| Start Date | 2022-01-11 |
| Est. Completion | 2024-07-31 |
| Phase | Phase 3 |
What the finished NCT05112900 record still lists
NCT05112900 is an interventional study that assigns participants to a tested intervention. Its 7,122 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (823% higher).
The record links to 0 conditions, and to 2 interventions - of which Text Messaging (TM) is the first listed.
NCT05112900 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05112900 about?
NCT05112900 is a clinical study titled "Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts)". This project will address key testing challenges in Utah schools by building on collaborations with public school districts, private schools, charter schools and with Utah Department of Health on coronavirus disease (COVID-19) testing and existing infrastructure. The study team will work closely wit...
What is the current status of trial NCT05112900?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 7,122 participants. The study started on 2022-01-11. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT05112900?
The interventions under investigation include: Text Messaging (TM) (BEHAVIORAL), Text Messaging + Health Navigation (TM+HN) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05112900?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05112900's enrollment target sits among peer trials
7,122 34th of 2000 higher than 1,967 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
- NCT05049837 · 7,200 participants
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
- NCT06714929 · 7,200 participants · NA
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI